• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾上腺皮质癌经典和新型实验细胞模型中类固醇生成信号的全面研究。

A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma.

机构信息

Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, 25124 Brescia, Italy.

Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), 8091 Zürich, Switzerland.

出版信息

Cells. 2022 Apr 24;11(9):1439. doi: 10.3390/cells11091439.

DOI:10.3390/cells11091439
PMID:35563746
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9103477/
Abstract

Adrenocortical carcinoma is a heterogeneous and aggressive cancer that originates from steroidogenic cells within the adrenal cortex. In this study, we have assessed for the preclinical gold standard NCI-H295 in direct comparison with the more recently established MUC-1 and a here newly reported ACC cell line (TVBF-7) the mutational status of important driver genes (TP53, MEN1, PRKAR1A, CTNNB1, APC, ZNRF-3, IGF-2, EGFR, RB1, BRCA1, BRCA2, RET, GNAS and PTEN), Wnt-signaling specificities (CTNNB1 mutation vs. APC mutation vs. wildtype), steroidogenic-(CYP11A1, CYP17A1, HSD3B2, HSD17B4, CYP21A2, CYP11B1, CYP11B2, MC2R, AT1R) and nuclear-receptor-signaling (AR, ER, GCR), varying electrophysiological potentials as well as highly individual hormone secretion profiles (Cortisol, Aldosterone, DHEA, DHEAS, Testosterone, 17-OH Progesterone, among others) which were investigated under basal and stimulated conditions (ACTH, AngII, FSK). Our findings reveal important genetic and pathophysiological characteristics for these three cell lines and reveal the importance of such cell-line panels reflecting differential endocrine functionalities to thereby better reflect clinically well-known ACC patient heterogeneities in preclinical studies.

摘要

肾上腺皮质癌是一种异质性和侵袭性的癌症,起源于肾上腺皮质中的类固醇生成细胞。在这项研究中,我们评估了 NCI-H295 这一临床前金标准,并与最近建立的 MUC-1 以及我们新报道的 ACC 细胞系(TVBF-7)进行了直接比较,评估了重要驱动基因(TP53、MEN1、PRKAR1A、CTNNB1、APC、ZNRF-3、IGF-2、EGFR、RB1、BRCA1、BRCA2、RET、GNAS 和 PTEN)、Wnt 信号特异性(CTNNB1 突变与 APC 突变与野生型)、类固醇生成(CYP11A1、CYP17A1、HSD3B2、HSD17B4、CYP21A2、CYP11B1、CYP11B2、MC2R、AT1R)和核受体信号(AR、ER、GCR)、不同的电生理潜能以及高度个体化的激素分泌谱(皮质醇、醛固酮、DHEA、DHEAS、睾酮、17-OH 孕酮等)的突变状态,这些都是在基础状态和刺激状态(ACTH、AngII、FSK)下进行的。我们的发现揭示了这三个细胞系的重要遗传和病理生理学特征,并揭示了此类细胞系面板的重要性,这些面板反映了不同的内分泌功能,从而在临床前研究中更好地反映了众所周知的 ACC 患者异质性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c7/9103477/2d561d117bae/cells-11-01439-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c7/9103477/17c8a5892d71/cells-11-01439-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c7/9103477/4af0b1117d76/cells-11-01439-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c7/9103477/6743660d5288/cells-11-01439-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c7/9103477/119c5237ce3f/cells-11-01439-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c7/9103477/2c10af31c17b/cells-11-01439-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c7/9103477/2d561d117bae/cells-11-01439-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c7/9103477/17c8a5892d71/cells-11-01439-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c7/9103477/4af0b1117d76/cells-11-01439-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c7/9103477/6743660d5288/cells-11-01439-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c7/9103477/119c5237ce3f/cells-11-01439-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c7/9103477/2c10af31c17b/cells-11-01439-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7c7/9103477/2d561d117bae/cells-11-01439-g006.jpg

相似文献

1
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma.肾上腺皮质癌经典和新型实验细胞模型中类固醇生成信号的全面研究。
Cells. 2022 Apr 24;11(9):1439. doi: 10.3390/cells11091439.
2
1alpha,25-Dihydroxyvitamin D3 affects hormone production and expression of steroidogenic enzymes in human adrenocortical NCI-H295R cells.1α,25-二羟基维生素D3影响人肾上腺皮质NCI-H295R细胞中激素的产生及类固醇生成酶的表达。
Biochim Biophys Acta. 2010 Sep;1801(9):1056-62. doi: 10.1016/j.bbalip.2010.04.009. Epub 2010 Apr 24.
3
Combined steroidogenic characters of fetal adrenal and Leydig cells in childhood adrenocortical carcinoma.儿童肾上腺皮质癌中胎儿肾上腺和睾丸间质细胞的联合类固醇生成特征。
J Steroid Biochem Mol Biol. 2016 May;159:86-93. doi: 10.1016/j.jsbmb.2016.02.031. Epub 2016 Mar 3.
4
Human adrenocortical NCI-H295 cells express VIP receptors. Steroidogenic effect of vasoactive intestinal peptide (VIP).人肾上腺皮质NCI-H295细胞表达血管活性肠肽(VIP)受体。血管活性肠肽(VIP)的类固醇生成作用。
Peptides. 1998;19(9):1511-7. doi: 10.1016/s0196-9781(98)00115-6.
5
Development of new preclinical models to advance adrenocortical carcinoma research.开发新的临床前模型以推进肾上腺皮质癌研究。
Endocr Relat Cancer. 2018 Apr;25(4):437-451. doi: 10.1530/ERC-17-0447. Epub 2018 Jan 25.
6
Mitotane exhibits dual effects on steroidogenic enzymes gene transcription under basal and cAMP-stimulating microenvironments in NCI-H295 cells.米托坦在 NCI-H295 细胞的基础和 cAMP 刺激微环境下对甾体生成酶基因转录表现出双重作用。
Toxicology. 2012 Aug 16;298(1-3):14-23. doi: 10.1016/j.tox.2012.04.007. Epub 2012 Apr 23.
7
Disorganized Steroidogenesis in Adrenocortical Carcinoma, a Case Study.肾上腺皮质癌中类固醇生成紊乱:一项病例研究
Endocr Pathol. 2017 Mar;28(1):27-35. doi: 10.1007/s12022-016-9441-8.
8
Melanocortin 2 receptor-associated protein (MRAP) and MRAP2 in human adrenocortical tissues: regulation of expression and association with ACTH responsiveness.黑素皮质素 2 受体相关蛋白(MRAP)及其 2 型在人肾上腺皮质组织中的表达调控及其与 ACTH 反应性的关系。
J Clin Endocrinol Metab. 2012 May;97(5):E747-54. doi: 10.1210/jc.2011-2328. Epub 2012 Mar 14.
9
DNA Methylation of Steroidogenic Enzymes in Benign Adrenocortical Tumors: New Insights in Aldosterone-Producing Adenomas.良性肾上腺皮质肿瘤中类固醇生成酶的 DNA 甲基化:醛固酮产生性腺瘤的新见解。
J Clin Endocrinol Metab. 2020 Dec 1;105(12). doi: 10.1210/clinem/dgaa585.
10
Adropin Stimulates Proliferation and Inhibits Adrenocortical Steroidogenesis in the Human Adrenal Carcinoma (HAC15) Cell Line. adipokine 刺激人肾上腺皮质癌细胞(HAC15)增殖并抑制其类固醇生成。
Front Endocrinol (Lausanne). 2020 Oct 8;11:561370. doi: 10.3389/fendo.2020.561370. eCollection 2020.

引用本文的文献

1
Iron Oxide Nanoparticle Uptake, Toxicity, and Steroidogenesis in Adrenocortical Carcinoma Cells Using a Multicellular in vitro Model.使用多细胞体外模型研究肾上腺皮质癌细胞对氧化铁纳米颗粒的摄取、毒性及类固醇生成
Int J Nanomedicine. 2025 Aug 29;20:10487-10502. doi: 10.2147/IJN.S519937. eCollection 2025.
2
Bimodal Genomic Approach Predicting Semaphorin 7A (SEMA7A) as Prognostic Biomarker in Adrenocortical Carcinoma.预测信号素7A(SEMA7A)作为肾上腺皮质癌预后生物标志物的双峰基因组方法。
Cancers (Basel). 2025 Jun 21;17(13):2078. doi: 10.3390/cancers17132078.
3
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas.

本文引用的文献

1
Ribociclib Cytotoxicity Alone or Combined With Progesterone and/or Mitotane in in Vitro Adrenocortical Carcinoma Cells.利波西利单独或联合孕激素和/或米托坦在体外肾上腺皮质癌细胞中的细胞毒性。
Endocrinology. 2022 Feb 1;163(2). doi: 10.1210/endocr/bqab248.
2
Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer Progression.过氧化物酶体增殖物激活受体γ配体罗格列酮刺激肾上腺皮质癌中CXCL12的表达可损害癌症进展。
J Pers Med. 2021 Oct 27;11(11):1097. doi: 10.3390/jpm11111097.
3
Novel Insights into the Molecular Regulation of Ribonucleotide Reductase in Adrenocortical Carcinoma Treatment.
胰岛素样生长因子1受体(IGF1R)及胰岛素受体(IR)的表达与定位在肾上腺皮质癌中的新作用
Cell Commun Signal. 2025 Mar 4;23(1):119. doi: 10.1186/s12964-025-02115-0.
4
Development and Characterization of 3-Dimensional Cell Culture Models of Adrenocortical Carcinoma.肾上腺皮质癌三维细胞培养模型的建立与特性分析
Endocrinology. 2024 Nov 26;166(1). doi: 10.1210/endocr/bqae159.
5
Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas.靶向丝状肌动蛋白(FLNA)调节的Wee1激酶在肾上腺皮质癌中的治疗潜力
Int J Cancer. 2025 Mar 15;156(6):1256-1271. doi: 10.1002/ijc.35239. Epub 2024 Nov 11.
6
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma.Dlk1是一种新型的肾上腺皮质干/祖细胞标志物,可预测肾上腺皮质癌的恶性程度。
bioRxiv. 2024 Aug 22:2024.08.22.609117. doi: 10.1101/2024.08.22.609117.
7
A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma Cell Lines, PDX, and Patient Samples.数据库工具整合肾上腺皮质癌细胞系、PDX 和患者样本的基因组和药物数据。
Cancer Res Commun. 2024 Sep 1;4(9):2384-2398. doi: 10.1158/2767-9764.CRC-24-0100.
8
LncRNA ZFHX4-AS1 as a novel biomarker in adrenocortical carcinoma.长链非编码RNA ZFHX4-AS1作为肾上腺皮质癌的一种新型生物标志物
Transl Androl Urol. 2024 Jul 31;13(7):1188-1205. doi: 10.21037/tau-23-649. Epub 2024 Jul 16.
9
The 3D in vitro Adrenoid cell model recapitulates the complexity of the adrenal gland.该 3D 体外腺样体细胞模型再现了肾上腺的复杂性。
Sci Rep. 2024 Apr 5;14(1):8044. doi: 10.1038/s41598-024-58664-w.
10
Zona Glomerulosa-Derived Klotho Modulates Aldosterone Synthase Expression in Young Female Mice.肾小球带衍生的 Klotho 调节年轻雌性小鼠醛固酮合酶的表达。
Endocrinology. 2024 Mar 29;165(5). doi: 10.1210/endocr/bqae040.
肾上腺皮质癌治疗中核糖核苷酸还原酶分子调控的新见解
Cancers (Basel). 2021 Aug 20;13(16):4200. doi: 10.3390/cancers13164200.
4
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer.孕酮、他莫昔芬及其联合用药对人肾上腺皮质癌细胞实验模型的细胞毒性作用。
Front Endocrinol (Lausanne). 2021 Apr 26;12:669426. doi: 10.3389/fendo.2021.669426. eCollection 2021.
5
A novel patient-derived cell line of adrenocortical carcinoma shows a pathogenic role of germline MUTYH mutation and high tumour mutational burden.一种新型的肾上腺皮质癌患者来源细胞系显示种系 MUTYH 突变与高肿瘤突变负担的致病性作用。
Eur J Endocrinol. 2021 May 4;184(6):823-835. doi: 10.1530/EJE-20-1423.
6
The Nexus of Endocrine Signaling and Cancer: How Steroid Hormones Influence Genomic Stability.内分泌信号与癌症的关联:类固醇激素如何影响基因组稳定性
Endocrinology. 2021 Jan 1;162(1). doi: 10.1210/endocr/bqaa177.
7
Steroid metabolites for diagnosing and predicting clinicopathological features in cortisol-producing adrenocortical carcinoma.类固醇代谢产物可用于诊断和预测分泌皮质醇的肾上腺皮质癌的临床病理特征。
BMC Endocr Disord. 2020 Nov 23;20(1):173. doi: 10.1186/s12902-020-00652-y.
8
Diagnostic testing of autonomous cortisol secretion in adrenal incidentalomas.肾上腺偶发瘤自主性皮质醇分泌的诊断检测
Endocr Connect. 2020 Oct;9(10):963-970. doi: 10.1530/EC-20-0419.
9
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study.EURINE-ACT 研究中尿类固醇代谢组学在肾上腺意外瘤鉴别诊断中的应用:一项前瞻性试验验证研究。
Lancet Diabetes Endocrinol. 2020 Sep;8(9):773-781. doi: 10.1016/S2213-8587(20)30218-7. Epub 2020 Jul 23.
10
Next-generation therapies for adrenocortical carcinoma.肾上腺皮质癌的下一代治疗方法。
Best Pract Res Clin Endocrinol Metab. 2020 May;34(3):101434. doi: 10.1016/j.beem.2020.101434. Epub 2020 Jun 18.